Klivira
Request demo

Automate Xarelto Prior Authorization Workflows

Efficiently manage Xarelto prior authorization requests with Klivira's intelligent automation platform, designed to streamline your revenue cycle operations and accelerate patient access to critical therapy.

Navigating Xarelto prior authorization presents significant administrative challenges for healthcare organizations, from managing varying formulary tiers and step therapy requirements to ensuring comprehensive clinical documentation. These complexities often lead to delays in patient care and increased administrative burden on your prior authorization coordinators and revenue cycle teams.

Understanding Xarelto Prior Authorization Requirements

Xarelto (rivaroxaban) is a direct oral anticoagulant (DOAC) prescribed for critical indications such as atrial fibrillation and venous thromboembolism (VTE). Due to its cost and clinical considerations, most payers require prior authorization. Requirements often include documentation of diagnosis, previous anticoagulant trials, contraindications to alternative therapies, and specific clinical criteria.

Common Challenges in Xarelto Prior Authorization

  • **Payer-Specific Criteria:** Each health plan may have unique clinical criteria and documentation demands for Xarelto, including step therapy protocols.
  • **Manual Data Extraction:** Identifying and compiling necessary patient data from EMRs for submission is a labor-intensive process.
  • **Denial Management:** High denial rates for DOACs contribute to rework, delayed care, and lost revenue.
  • **Staff Burden:** Prior authorization coordinators spend excessive time on phone calls, faxes, and manual portal entries.

Klivira's Solution for Xarelto Prior Authorization Automation

Klivira integrates directly with your EMR system to automate the Xarelto prior authorization process. Our platform leverages AI and machine learning to accurately extract relevant clinical data, populate authorization forms, and submit requests via X12 278 transactions or direct payer portal automation. This reduces manual effort, accelerates submission times, and improves approval rates.

Key Data Points Klivira Automates for Xarelto PA

Klivira's system is engineered to identify and utilize critical information for Xarelto prior authorizations. This includes patient demographics, ICD-10 codes for atrial fibrillation or VTE, relevant lab results (e.g., renal and hepatic function), medication history, and documentation of previous anticoagulant trials or contraindications to warfarin, ensuring comprehensive submissions.

Seamless Integration with Your Existing Infrastructure

Klivira connects with major EMRs via SMART on FHIR and other secure APIs, ensuring a frictionless workflow for Xarelto prior authorization. Our platform also supports the Da Vinci PAS initiative for electronic prior authorization, streamlining communication between providers and payers and reducing the administrative burden associated with manual processes.

Ensuring Data Security and Compliance

Handling PHI and ePHI during prior authorization requires robust security protocols. Klivira operates with a commitment to data privacy and security, adhering to HIPAA guidelines. We recommend discussing Klivira's technical safeguards and operational procedures with your internal compliance team to ensure alignment with your organizational policies.

Frequently asked questions

What are common reasons for Xarelto prior authorization denials?

Common denial reasons include insufficient documentation of medical necessity, failure to meet step therapy requirements, lack of previous anticoagulant trials, or incomplete submission of clinical data such as relevant lab results or contraindications to preferred alternatives. Klivira helps mitigate these by ensuring all required data points are included in the initial submission.

How does Klivira handle step therapy requirements for Xarelto?

Klivira's system is configured to identify payer-specific step therapy rules for Xarelto. It prompts for or automatically extracts documentation of trials with preferred alternatives (e.g., warfarin) or justifications for why step therapy is not clinically appropriate, ensuring that these critical details are part of the prior authorization submission.

Can Klivira integrate with our EMR to pull Xarelto-specific patient data?

Yes, Klivira integrates with leading EMR systems using secure, standards-based protocols like SMART on FHIR. This allows our platform to accurately and efficiently extract all necessary patient data, including diagnoses, medication history, lab results, and clinical notes, directly from your EMR to populate Xarelto prior authorization requests.

Does Klivira automate submissions to all payers for Xarelto prior authorization?

Klivira supports a broad network of payers, facilitating electronic prior authorization submissions via X12 278 and direct payer portal automation. While coverage varies, our goal is to maximize electronic submission capabilities across the payer landscape, significantly reducing manual effort for your team.

What is the typical turnaround time for Xarelto prior authorization using Klivira?

By automating data extraction, form completion, and submission, Klivira significantly reduces the administrative portion of the turnaround time. While final approval times are payer-dependent, our platform ensures that your requests are submitted accurately and promptly, minimizing delays caused by incomplete or incorrect documentation.

Related coverage

Automate prior authorization by payer

Automate prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo